Business
What Goldman Sachs is saying about the CSL (ASX:CSL) share price after its R&D update
Image source: Getty Images
Last week was a reasonably disappointing one for the CSL Limited (ASX: CSL) share price.
Despite releasing its research and development (R&D) update for 2021, the biotherapeutics company’s shares ended the period with a weekly decline of 0.5%.
What was the reaction…
Continue Reading
-
Noosa News23 hours agoSerious traffic crash, Noosa – Sunshine Coast
-
Noosa News23 hours ago$20 million program to help women return to work
-
General19 hours agoAustralia’s Diamonds defeat South Africa’s Proteas 65-42 in third netball Test
-
General20 hours agoThousands join pro-Palestinian rallies in towns and cities across Australia amid ceasefire